Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 1/20 | 0.52 |
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.51 |
| ▸ | KISS1R | Q969F8 | 5/20 | 0.51 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.49 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30093138 | 1.00 | GHSR (0.52) | GHSRIL23RKISS1RCTSBCTSK | |
| SCHEMBL30093121 | 0.97 | GHSR (0.54) | GHSRIL23RKISS1RACEMAGI3 | |
| SCHEMBL30130569 | 0.95 | KISS1R (0.55) | GHSRIL23RKISS1RCTSBCTSK | |
| SCHEMBL30130539 | 0.95 | KISS1R (0.55) | GHSRIL23RKISS1RCTSBCTSK | |
| SCHEMBL30130541 | 0.95 | KISS1R (0.55) | GHSRIL23RKISS1RCTSBCTSK | |
| SCHEMBL30505871 | 0.93 | NPBWR1 (0.58) | GHSRIL23RKISS1RCTSBCTSK | |
| SCHEMBL30505874 | 0.93 | NPBWR1 (0.58) | GHSRIL23RKISS1RCTSBCTSK | |
| SCHEMBL30053472 | 0.93 | ERAP2 (0.56) | GHSRKISS1RCTSBCTSK | |
| SCHEMBL29800070 | 0.92 | IL23R (0.51) | GHSRIL23RKISS1RACEMAGI3 | |
| SCHEMBL30305302 | 0.92 | KISS1R (0.54) | IL23RKISS1RACEMAGI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115397836-A | Novel antibacterial peptide and application thereof | 安尼根有限公司 | 2022-11-25 | — | — | CN | claimed |